Watch our latest corporate film - chapter four
Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
See what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Our significant order book increase in a growing market is a great sign of confidence.
Play a key role in reaching the world's net zero targets.
By operating efficiently, delivering on our customer commitments and realising our strategic goals, we ensure long term success and sustainability.
Investors
We announced our results for the full year ended 31 December 2024 on 13 March 2025.
We provide our investors with information about our bonds, prospectuses, financial statements, credit ratings and taxation.
+44 (0)1753 660 660
investors@urenco.com